3D0I

Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2

3D0I の概要

• エントリーDOI: 10.2210/pdb3d0i/pdb
• 関連するPDBエントリー: 2AJF 3D0G 3D0H
• 分子名称: Angiotensin-converting enzyme 2, Spike glycoprotein, 2-acetamido-2-deoxy-alpha-D-glucopyranose, ... (7 entities in total)
• 機能のキーワード: sars coronavirus, spike protein, receptor-binding domain, rbd, angiotensin-converting enzyme 2, ace2, virus-host interface, host adaptation, cross-species infections, human, palm civet, carboxypeptidase, chloride, glycoprotein, hydrolase, membrane, metal-binding, metalloprotease, protease, secreted, transmembrane, envelope protein, host-virus interaction, lipoprotein, palmitate, virion, virulence
• 由来する生物種: Paguma larvata (Masked palm civet); 詳細
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 180463.97

構造登録者

Li, F. (登録日: 2008-05-01, 公開日: 2008-07-08, 最終更新日: 2024-10-16)

主引用文献

Li, F.
Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections
J.Virol., 82:6984-6991, 2008

PubMed Abstract: It is believed that a novel coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV), was passed from palm civets to humans and caused the epidemic of SARS in 2002 to 2003. The major species barriers between humans and civets for SARS-CoV infections are the specific interactions between a defined receptor-binding domain (RBD) on a viral spike protein and its host receptor, angiotensin-converting enzyme 2 (ACE2). In this study a chimeric ACE2 bearing the critical N-terminal helix from civet and the remaining peptidase domain from human was constructed, and it was shown that this construct has the same receptor activity as civet ACE2. In addition, crystal structures of the chimeric ACE2 complexed with RBDs from various human and civet SARS-CoV strains were determined. These structures, combined with a previously determined structure of human ACE2 complexed with the RBD from a human SARS-CoV strain, have revealed a structural basis for understanding the major species barriers between humans and civets for SARS-CoV infections. They show that the major species barriers are determined by interactions between four ACE2 residues (residues 31, 35, 38, and 353) and two RBD residues (residues 479 and 487), that early civet SARS-CoV isolates were prevented from infecting human cells due to imbalanced salt bridges at the hydrophobic virus/receptor interface, and that SARS-CoV has evolved to gain sustained infectivity for human cells by eliminating unfavorable free charges at the interface through stepwise mutations at positions 479 and 487. These results enhance our understanding of host adaptations and cross-species infections of SARS-CoV and other emerging animal viruses.

PubMed: 18448527
DOI: 10.1128/JVI.00442-08

実験手法

X-RAY DIFFRACTION (2.9 Å)